Skip to Content

ViaDerma Inc VDRM

Morningstar Rating
$0.01 0.00 (11.22%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VDRM is trading within a range we consider fairly valued.
Price
$0.01
Fair Value
$7.87
Uncertainty
Extreme
1-Star Price
$5.88
5-Star Price
$5.54
Economic Moat
Cpzvq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VDRM is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.010.02
Bid/Ask
$0.01 / $0.01
Market Cap
$1,496.81
Volume/Avg
301,922 / 1.6 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
75

Valuation

Metric
VDRM
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
VDRM
Quick Ratio
1.95
Current Ratio
2.15
Interest Coverage
5.54
Quick Ratio
No chart available

Profitability

Metric
VDRM
Return on Assets (Normalized)
5.33%
Return on Equity (Normalized)
6.91%
Return on Invested Capital (Normalized)
6.92%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AQxqcdylwfMkd$74.6 Bil
MKKGY
Merck KGaA ADRSjmlcgtnhGjydsgd$70.9 Bil
HLN
Haleon PLC ADRBrrscmxgJhyj$37.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRQbhtzkgwXfcx$14.9 Bil
VTRS
Viatris IncYmnkhcwxJbyh$13.9 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHzvyyytQmgx$12.2 Bil
CTLT
Catalent IncRngxzldcpNzcmsr$10.3 Bil
PRGO
Perrigo Co PLCQkggrjndtXwn$4.3 Bil
CURLF
Curaleaf Holdings IncHldbnkqfGjtt$3.9 Bil
PBH
Prestige Consumer Healthcare IncScmczbsyxQblxvd$3.4 Bil

Sponsor Center